Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
SeekingAlpha
SeekingAlpha
MarketWatch
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.